Label Changes for:

Zyvox (linezolid) TabletsZyvox (linezolid) IV InjectionZyvox (linezolid) for Oral Suspension

May 2013

Changes have been made to the PRECAUTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)  

 

May 2013

7 DRUG INTERACTIONS

7.2 Adrenergic and Serotonergic Agents
  • Linezolid has the potential for interaction with adrenergic and serotonergic agents. [see Warnings and Precautions (5.3, 5.6) and Clinical Pharmacology (12.3)]

 

December 2009

 

PRECAUTIONS 

Drug Interactions
  • update an observed reduction in linezolid plasma concentrations when co-administered with rifampin in a Phase 1 drug interaction study conducted in healthy volunteers

ADVERSE REACTIONS 

Postmarketing Experience
  • Superficial tooth discoloration and tongue discoloration have been reported with the use of linezolid. The tooth discoloration was removable with professional dental cleaning (manual descaling) in cases with known outcome.

 

Hide
(web5)